<?xml version="1.0" encoding="UTF-8"?>
<ref id="B4-pharmaceutics-12-00138">
 <label>4.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rassu</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Porcu</surname>
    <given-names>E.P.</given-names>
   </name>
   <name>
    <surname>Fancello</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Obinu</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Senes</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Galleri</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Migheli</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Gavini</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Giunchedi</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>Intranasal Delivery of Genistein-Loaded Nanoparticles as a Potential Preventive System against Neurodegenerative Disorders</article-title>
  <source>Pharmaceutics</source>
  <year>2019</year>
  <volume>11</volume>
  <elocation-id>8</elocation-id>
  <pub-id pub-id-type="doi">10.3390/pharmaceutics11010008</pub-id>
  <?supplied-pmid 30597930?>
  <pub-id pub-id-type="pmid">30597930</pub-id>
 </element-citation>
</ref>
